Search clinical trials for: Hematologic markers

Total 18413 results

IRCCS SYNLAB SDN
Fondazione Santobono Pausilipon

Recruiting

Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.

Acute Lymphoblastic Leukemia, Pediatric

Italy
Medical University of Graz

Not yet recruiting

Clock Proteins as Prognostic Markers (CLOCK-PM)

Severe Eosinophilic Asthma
Suhu Liu

Recruiting

Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)

Acute Myeloid Leukemia

United States
Hamilton Health Sciences Corporation
St. Joseph's Health Care London; Hamilton Academic Health Sciences Organization

Not yet recruiting

Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)

Chronic Kidney Diseases | Renal Failure

Canada
Assiut University

Not yet recruiting

Immune Markers in Pediatric ITP on Second Line Therapy

ITP - Immune Thrombocytopenia
Centro Cardiologico Monzino

Recruiting

Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers (IPNO)

Inflammation | Sleep Disorder | Hemostatic Disorder | Shift-Work Related Sleep Disturbance

Italy
University of Milano Bicocca

Recruiting

Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.

Inflammatory Markers | Myeloproliferative Disease

Italy
Assistance Publique - Hôpitaux de Paris

Recruiting

Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy. (PRONOSTIM)

Blood Cancer

France
University Hospital, Strasbourg, France

Recruiting

B-cell Chronic Lymphoid Malignancies Markers (MALYZOMA-II)

Follicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Hairy Cell Leukemia | Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia

France
Assistance Publique - Hôpitaux de Paris
Intergroupe Francophone du Myelome

Recruiting

Study of 4 Bone Turnover Markers in Patients With Multiple Myeloma Treated With Intravenous Bisphosphonate in Routine Care (AMBROBiMM)

Multiple Myeloma

France
University of California, San Diego
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Recruiting

Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE) (EoE)

Eosinophilic Esophagitis

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

Eosinophilia | Hypereosinophilic Syndrome

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pathophysiology of Acute Pain in Patients With Sickle Cell Disease

Sickle Cell Disease

United States
Meyer Children's Hospital IRCCS

Active, not recruiting

Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.

Cytopenia

Italy, United States, Belgium
Baylor College of Medicine

Active, not recruiting

Morphological Markers of Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease | Eosinophilic Esophagitis

United States
Gesellschaft fur Medizinische Innovation - Hamatologie...
ClinAssess GmbH

Completed

Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5q (MDS-LE-MON-5)

Myelodysplastic Syndromes

Germany
University Health Network, Toronto

Enrolling by invitation

Ultrastructural Collagen Markers in Ehlers Danlos Syndromes

Ehlers-Danlos Syndrome | Hypermobile EDS (hEDS) | Classical Ehlers-Danlos Syndrome

Canada
Azienda Ospedaliera Universitaria Policlinico "G...

Completed

Physical Exercise, Motor Activity and Depression in Post-mastectomy Pain Syndrome

Chronic Pain

Italy
MGC Pharmaceuticals d.o.o

Completed

Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 (CimetrA)

Covid19 | Corona Virus Infection

Israel
Thomas Lund

Completed

Prolonged Protection From Bone Disease in Multiple Myeloma (Magnolia)

Multiple Myeloma

Denmark
Centre Hospitalier Universitaire de Nīmes

Completed

Analysis of the Coagulopathy Developed by COVID-19 Infected Patients (COVID-TGT)

COVID-19 | Sepsis | Blood Coagulation Disorders | Disseminated Intravascular Coagulation | Thrombin

France
MGC Pharmaceuticals d.o.o

Active, not recruiting

Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 (CimetrA)

Covid19 | Corona Virus Infection | SARS-CoV Infection

Israel
The Affiliated Hospital of Qingdao University

Completed

Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients

Liver Cirrhosis | Portal Vein Thrombosis | Neutrophil Extracellular Trap Formation

China
Queen Fabiola Children's University Hospital

Active, not recruiting

Study of Biological Markers in Children With Sickle Cell Disease

Sickle Cell Disease

Belgium
National Cancer Institute (NCI)

Terminated

Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

Monoclonal Gammopathy of Undetermined Significance | Smoldering Myeloma

United States
Beijing Tiantan Hospital

Unknown

Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE) (FAVORITE)

Iron-deficiency | Cerebral Infarction | Dementia, Vascular | TIA | Vascular Cognitive Impairment

China
University of Westminster
Gencor Pacific Group

Completed

Effect of Ferrous iROn and cUrcumin sTatus on Inflammatory and Neurotrophic markErs (Fe-ROUTINE)

Iron Deficiency (Without Anemia)

United Kingdom
Assiut University

Unknown

Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura

Immune Thrombocytopenia
Northwell Health
National Cancer Institute (NCI); University of California, San Diego

Completed

Ultrasonography in Hemophilic Joint Disease and Serum Markers

Hemophilia A | Hemophilia B | Hemarthroses

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)

Leukemia | Myelodysplastic Syndrome

United States
Sunnybrook Health Sciences Centre
Queen's University; Ontario Molecular Pathology Research Network

Unknown

Mutational Analysis as a Prognostic and Predictive Marker of Cardiovascular (CVD) Disease in Patients With Myelodysplasia

Cardiovascular Diseases | Inflammation | MDS

Canada
University of Maryland, Baltimore

Completed

Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women

Non-anemic Iron Deficiency

United States
University Hospital, Bordeaux

Completed

Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura (SPLENOTIR)

Immune Thrombocytopenic Purpura | Splenectomy; Status
Assiut University

Unknown

Cystatin c and Beta 2 Microglobulin in Thalassemic Children.

Blood Disease
Assistance Publique - Hôpitaux de Paris
Association Clinique Thérapeutique Infantile du val de Marne; Association Française... and other collaborators

Completed

Iron Deficiency (ID) in Infants (CARMA)

Iron Deficiency in Young Children Living in France

France
Kuopio University Hospital

Completed

Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients

Sepsis

Finland
University Hospital, Lille

Completed

Identification of New Markers in the Hypereosinophilic Syndrome (SHE)

Hypereosinophilic Syndrome

France
GlaxoSmithKline

Completed

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control

Asthma

United States, Argentina, Canada, France, Netherlands, Spain, Ukraine, Bulgaria, Estonia, Belgium, Peru, Russian Federation, Germany, Greece, Czechia, Italy, United Kingdom, Norway, Slovakia
Vanderbilt-Ingram Cancer Center

Completed

First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade

Multiple Myeloma

United States
Medical University of South Carolina
Genentech, Inc.

Completed

Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

Multiple Myeloma

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders (CTIM3)

Myeloproliferative Neoplasms

France
University Hospital, Montpellier

Completed

Hepcidine and Iron Deficiency in Critically Ill Patients (HEPCIDANE)

Critical Illness | Anemia | Hospitalized for 5 Days or More

France
University of California, Davis

Completed

Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation

Iron Overload | Oxidative Stress | Iron-deficiency Anemia

United States
Novartis Pharmaceuticals

Completed

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Breast Cancer | Prostate Cancer | Bone Metastasis

Germany
University Hospital, Strasbourg, France
Institut National de la Santé Et de la Recherche Médicale, France; Louis Pasteur... and other collaborators

Terminated

Markers of Defective Membrane Remodelling in Scott-like Syndromes

Unexplained Isolated Provoked Hemorrhages | Familial Bleeding Disorder | Scott Syndrome

France, Martinique
Janssen-Cilag International NV

Completed

Velcade Consolidation Bone Study

Multiple Myeloma

Turkey, Greece, Czech Republic, Austria, Germany, Sweden, United Kingdom, Denmark
Regional Hospital Holstebro

Unknown

0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary Hiparthrosis (KIPA)

Nephrotoxicity

Denmark
Universidade Federal do Rio de Janeiro
Rio de Janeiro State Research Supporting Foundation (FAPERJ)

Completed

Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients

Insulin Resistance | Thrombophilia | Psychosis

Brazil
University Hospital, Basel, Switzerland

Completed

Iron Homoeostasis in Inflammation

Inflammation | Bacterial Infections and Mycoses | Anemia, Iron-Deficiency | Iron Overload

Switzerland
Samsung Medical Center

Completed

Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome

Korea, Republic of

Search clinical trials for: Hematologic markers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations